| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_babc5456909e8a1ce32f6ce65f61407b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-32 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-79 |
| filingDate |
2010-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e687668402f98f5d450ade20734617f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fde3049d00e0d4717c72cd61dfd731d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8acea9bd772a79fcd6291dee7fc9da43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3874d9f48861d4ae7d6b09b0f806884c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20212bb3947d3014364d669533e1ba47 |
| publicationDate |
2012-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120008366-A |
| titleOfInvention |
Composition for the prevention and treatment of colitis disease containing a compound isolated from Schisandra chinensis extract as an active ingredient |
| abstract |
The present invention relates to a composition containing a compound isolated from the Schizandra chinensis extract as an active ingredient, and in particular, deoxyschisandrin is oxidized by reactive oxygen species which induces an excessive immune response known as a cause of colitis. By confirming the protective effect against cellular damage through the inhibition of NF-κB activity in the stress stimulation and the effect of inhibiting the expression of chemokine IL-8 by stimulation of the inflammatory cytokine TNF-α, the composition prevents colitis disease And it can be usefully used as a therapeutic pharmaceutical composition or health functional food. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014007536-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9895421-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101379111-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101586016-B1 |
| priorityDate |
2010-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |